Wiadomości Eulerpool G1 Therapeutics

Eulerpool-AFX G1 Therapeutics

G1 Therapeutics Wiadomości o akcjach

G1 Therapeutics jest obserwowany przez wielu dziennikarzy i inwestorów na całym świecie. Najnowsze wiadomości G1 Therapeutics przedstawiamy tutaj.

• 31 maja ·

  Yahoo
  G1 Therapeutics (NASDAQ:GTHX shareholders incur further losses as stock declines 19% this week, taking three-year losses to 84%
• 28 maja ·

  Benzinga
  Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
• 28 maja ·

  Benzinga
  12 Health Care Stocks Moving In Tuesday's Intraday Session
• 28 maja ·

  TipRanks
  Buy Rating Affirmed: G1 Therapeutics’ Cosela Shows Significant Survival Benefits in mTNBC
• 28 maja ·

  Yahoo
  Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC)
• 28 maja ·

  TipRanks
  Buy Rating Affirmed for G1 Therapeutics Amid Promising Clinical Outcomes
• 28 maja ·

  Thefly.com
  G1 Therapeutics' trilaciclib combiation improves breast cancer overall survival
• 28 maja ·

  Seeking Alpha
  G1 Therapeutics slips after new breast cancer data for lead asset
• 23 maja ·

  Yahoo
  G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting
• 23 maja ·

  Thefly.com
  G1 Therapeutics announces upcoming presentation on trilaciclib at ASOCO